Back to
Cerity Partners LLC
PRAX
Showing 8 of 10 quarters
Position history for
Cerity Partners LLC's holdings in PRAXIS PRECISION MEDICINES I
Yes. Cerity Partners holds 1,159 shares of PRAX (Praxis Precision Medicines), worth $388,023, as of its Q2 2026 13F filing. It reduced the position by 440 shares (-27.5%) from Q1 2026. Cerity Partners has held PRAX since Q2 2025, across 5 quarterly 13F filings.
Current Value
$388,023
Current Shares
1,159
Total Value Change
+$135,537
Total Shares Change
-3,229
Quarter-by-Quarter History